ChromaDex: Pioneering NAD+ research for better health

Leading the industry and setting the gold standard in cellular well-being

With an unwavering commitment to scientific integrity and quality, ChromaDex is at the forefront of the NAD+ space. Short for nicotinamide adenine dinucleotide, NAD+ is a coenzyme vital to cellular health, playing a critical role in key cellular processes such as energy metabolism and cellular repair.

“Our philosophy is rooted in a fierce commitment to truth above all else,” says Rob Fried, CEO of ChromaDex and founder of Tru Niagen®. “We believe in the long-term value of trust and scientific excellence.”

This principle has driven ChromaDex’s success, enabling the global bioscience company to innovate and deliver premium products. Its portfolio includes the ingredient Niagen®, a patented form of nicotinamide riboside (NR). Among all NAD+ boosters—NR, NMN and the NAD+ molecule itself—Niagen (NR) is the most efficient, safe and legally available NAD+ precursor. Niagen is the hero ingredient in ChromaDex’s flagship consumer dietary supplement brand, Tru Niagen. It is also featured in other innovations across multiple verticals and supplied to select ingredient partners.

ChromaDex’s foundation is built on scientific rigor and quality. With 33 peer-reviewed studies, Fried emphasizes they are committed to understanding how NAD+ functions, especially as people age. The company’s efforts have earned it a trusted reputation, not only in dietary supplements but also across emerging verticals.

Expanding into new markets, ChromaDex recently unveiled the first-of-its-kind pharmaceutical-grade Niagen (nicotinamide riboside chloride), which features Niagen IV (intravenous) and injections, and is planning for future growth in pharmaceuticals and cosmetics. After years of rigorous testing and regulatory approval of oral food-grade Niagen, the availability of pharmaceutical-grade Niagen for IV and injection—compounded by FDA-registered 503B pharmacies exclusively for clinics with a prescription—marks a significant step forward. Fried explains that their mission is to help people everywhere support NAD+, which is vital to how human bodies age and heal. By addressing multiple commercial verticals, ChromaDex continues to grow while maintaining its focus on delivering high-quality products backed by science.

While the dietary supplement industry can be a Wild West, Fried believes ChromaDex’s adherence to science and innovation sets it apart. He notes that the industry’s biggest challenges are due to companies that ignore regulations. ChromaDex invests heavily in quality and research, offering products supported by science, such as its highly regarded Tru Niagen.

At the heart of ChromaDex’s strategy is trustworthiness, that is, creating high-quality products backed by research. This long-term focus has helped the company cultivate loyal customers and attract key global business partners like Sinopharm, Watsons and Nestlé.

“When it comes to your or your family’s health, it’s important to look beyond advertisements and truly understand everything about the product you’re using,” advises Fried. “Our number one commitment is to our customers and partners, and we are dedicated to raising the bar in the industry to ensure other companies do the same.”

Learn more about ChromaDex at chromadex.com.